A critical advance in cancer study is occurring with the use of VHH fragments to reactivate mutated p53. This crucial malignant suppressor protein is frequently inactivated in various forms of malignancies, leading https://bookmarksoflife.com/story7704561/mini-antibodies-reactivate-the-p53-protein-a-new-hope-for-cancer-therapy